deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT02636231

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

A Phase II Randomized Controlled Study to Compare Endostar and IMRT vs. IMRT Alone for Locally Recurrent Nasopharyngeal Carcinoma Patients

Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Conditions Nasopharyngeal Carcinoma
Interventions Endostatins IMRT
Updated 12 times since 2017 Last updated: Jan 31, 2021 Started: Nov 30, 2015 Primary completion: Mar 31, 2020 Completion: Dec 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02636231, this PHASE2 trial focuses on Nasopharyngeal Carcinoma and remains ongoing. Sponsored by Affiliated Cancer Hospital & Institute of Guangzhou Medical University, it has been updated 12 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotRecruiting~Nov 2018 – ~Jan 2019 · 2 months · monthly snapshotRecruiting~Jan 2019 – ~Nov 2020 · 22 months · monthly snapshotRecruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotUnknown Status~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshotUnknown Status~Mar 2021 – ~Feb 2023 · 23 months · monthly snapshotActive Not Recruiting~Feb 2023 – ~Jul 2024 · 17 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotUnknown~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshotUnknown~Sep 2025 – present · 9 months · monthly snapshotUnknown

Change History

12 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE2

  2. Jun 2025 — Sep 2025 [monthly]

    Unknown PHASE2

  3. Sep 2024 — Jun 2025 [monthly]

    Unknown PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  5. Feb 2023 — Jul 2024 [monthly]

    Unknown Status PHASE2

    Status: Active Not Recruiting → Unknown Status

▶ Show 7 earlier versions

  1. Mar 2021 — Feb 2023 [monthly]

    Active Not Recruiting PHASE2

    Status: Unknown Status → Active Not Recruiting

  2. Jan 2021 — Mar 2021 [monthly]

    Unknown Status PHASE2

  3. Nov 2020 — Jan 2021 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

  4. Jan 2019 — Nov 2020 [monthly]

    Recruiting PHASE2

  5. Nov 2018 — Jan 2019 [monthly]

    Recruiting PHASE2

  6. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  7. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

    First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Affiliated Cancer Hospital & Institute of Guangzhou Medical University
  • First Affiliated Hospital of Gannan Medical University
  • First People's Hospital of Foshan
  • JiangXi Province Tumor Hospital
  • Second Affiliated Hospital of Nanchang University
  • Sun Yat-sen University
  • The Affiliated Ganzhou Hospital of Nanchang University
  • The First Affiliated Hospital of Clinical Medicine of G.D.P.U.
Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations